RCUS
Arcus Biosciences, Inc. · Healthcare · Market cap $3.4B
Insiders sold $3.1M net in the last 90 days ·2 sellers, 0 buyers· 7 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 24, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.4M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Aug 24, 2026
Azoy Alexander
Arcus Biosciences, Inc. (RCUS) has 42 SEC Form 4 filings (68 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 24, 2026.
Inside the rolling window, 7 insiders at Arcus Biosciences, Inc. reported no open-market purchases and 38 open-market sales totaling $14.4M. The most active filer is President Jaen Juan C. with 14 filings. Insiders have net sold $3.3M over the trailing 6 months. The most recent open-market filing is a sale of 2,827 shares by Chief Accounting Officer Azoy Alexander, dated Aug 21, 2026, worth $85K.
- Industry:Biotechnology
- CEO:Terry J. Rosen
- Employees:601
- HQ:Hayward, CA, US
- IPO:2018-03-14
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Accounting Officer | Sale | 2,827 | $85K | Aug 24 | -10.8% | SEC ↗ | |
| President | Sale | 48,502 | $1.5M | Jul 13 | -4.3% | SEC ↗ | |
| President | Sale | 20,067 | $574K | Jul 13 | -4.3% | SEC ↗ | |
Jaen Juan C.First in 6 months | President | Sale | 9,236 | $250K | Jun 24 | -6.7% | SEC ↗ |
Jaen Juan C.First in 6 months | President | Sale | 15,764 | $437K | Jun 24 | -6.7% | SEC ↗ |
Jaen Juan C.First in 6 months | President | Sale | 6,431 | $191K | Jun 24 | -6.7% | SEC ↗ |
Azoy AlexanderFirst in 6 months | Chief Accounting Officer | Sale | 2,562 | $66K | Jun 1 | +4.7% | SEC ↗ |
Goeltz II Robert C.First in 4 months | Chief Financial Officer | Sale | 7,763 | $199K | May 12 | +7.9% | SEC ↗ |
| President | Sale | 31,823 | $681K | Jan 7 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 6,552 | $153K | Jan 2 | — | SEC ↗ | |
| Chief Accounting Officer | Sale | 2,376 | $52K | Dec 18 | — | SEC ↗ | |
| Chief Accounting Officer | Sale | 2,113 | $47K | Dec 18 | — | SEC ↗ | |
| Chief Accounting Officer | Sale | 4,343 | $97K | Dec 18 | — | SEC ↗ | |
| President | Sale | 11,225 | $246K | Dec 18 | — | SEC ↗ | |
| President | Sale | 9,983 | $221K | Dec 18 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 11,225 | $246K | Dec 18 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 9,983 | $221K | Dec 18 | — | SEC ↗ | |
Tang Carolyn C.First filing | General Counsel | Sale | 7,658 | $168K | Dec 18 | — | SEC ↗ |
Tang Carolyn C.First filing | General Counsel | Sale | 6,810 | $151K | Dec 18 | — | SEC ↗ |
Markus RichardFirst filing | Chief Medical Officer | Sale | 5,052 | $111K | Dec 18 | — | SEC ↗ |
Markus RichardFirst filing | Chief Medical Officer | Sale | 4,494 | $100K | Dec 18 | — | SEC ↗ |
| Chief Financial Officer | Sale | 6,702 | $147K | Dec 18 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 5,960 | $132K | Dec 18 | — | SEC ↗ | |
ROSEN TERRY JFirst filing | Chief Executive Officer | Sale | 28,947 | $633K | Dec 18 | — | SEC ↗ |
ROSEN TERRY JFirst filing | Chief Executive Officer | Sale | 25,744 | $570K | Dec 18 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does RCUS have?
Arcus Biosciences, Inc. (RCUS) has 42 SEC Form 4 filings (68 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for RCUS?
The most recent Form 4 filing for RCUS on Tracefour is dated Aug 24, 2026.
Who is the most active insider at RCUS?
The most active SEC Form 4 filer at RCUS in the rolling window is President Jaen Juan C., with 14 filings.
What is the net insider flow at RCUS over the last 6 months?
Over the trailing 180 days, insiders at RCUS have net sold $3.3M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at RCUS in the current window?
Inside the rolling window, insiders at RCUS bought $0 and sold $14.4M based on SEC Form 4 filings.
Can I get alerts for RCUS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Arcus Biosciences, Inc. (RCUS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Arcus Biosciences, Inc. is in the Healthcare sector.